Dr. Mohammad Nadeemullah , MD
Internal Medicine • Brighton, MI
2305 Genoa Business Park Dr, Suite 120
Brighton, MI 481147004
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Mohammad Nadeemullah is listed in NPPES under Internal Medicine.
-
NPI assigned on June 13, 2006; this date does not establish years in practice.
-
Published CMS data list 102 Original Medicare Part B services in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Published rows only; this is not a quality measure.
-
Published Part B service records, 2023:
- 99223 — Initial hospital care with moderate level of medical decision making: 85 service units.
- 99233 — Subsequent hospital care with moderate levelof medical decision making: 17 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2022 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2023). CPT notice
See the full table · Guide: How to read Medicare Part B data
-
Published CMS data list 855 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Levothyroxine Sodium — 94 prescription fills, including refills.
- Tamsulosin Hcl — 74 prescription fills, including refills.
- Lisinopril — 38 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 36 records in the table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 75% of clinicians listed under Internal Medicine in Brighton, MI (2024, 18 clinicians with data). Median for this group: 2,262. Middle half: 861 to 4,583.
Close to the middle for Part D prescriptions among clinicians listed under Internal Medicine in Michigan (2024, 3,463 clinicians with data). Median for this group: 801. Middle half: 94 to 5,032.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 634 in 2019 to 102 in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019–2023.
Practice Location & Contact Primary Location
2305 Genoa Business Park Dr
Suite 120
Brighton, MI 481147004
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $17,062 in 2023
The total amount Medicare approved for these services in 2023. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
Paid by Medicare
About $13,594 in 2023
The part of the Medicare-allowed amount that Medicare itself paid in 2023, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
30-day fills
946 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$27,319 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2019
All general payments: $134.70 across 10 records.
By nature of payment
- Food and Beverage: $134.70 across 10 records.
Reporting-company totals (3 largest of 6)
- Pfizer Inc.: $49.83 across 4 records.
- Merck Sharp & Dohme Corporation: $22.73 across 2 records.
- Novo Nordisk Inc: $20.88 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2019 (published June 30, 2026).
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Brighton and Michigan
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 75% of clinicians listed under Internal Medicine in Brighton, MI (2024, 18 clinicians with data). Median for this group: 2,262. Middle half: 861 to 4,583.
Close to the middle for clinicians listed under Internal Medicine in Michigan (2024, 3,463 clinicians with data). Median for this group: 801. Middle half: 94 to 5,032.
Part D drug cost
A lower Part D drug cost than 80% of clinicians listed under Internal Medicine in Brighton, MI (2024, 18 clinicians with data). Median for this group: $237,259. Middle half: $48,814 to $338,304.
Close to the middle for clinicians listed under Internal Medicine in Michigan (2024, 3,463 clinicians with data). Median for this group: $66,958. Middle half: $1,946 to $462,816.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Nadeemullah are from 2023.
24 active clinicians are listed under Internal Medicine with a practice address in Brighton, MI (5,741 in Michigan).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Brighton
50% of these 24 clinicians have the CMS telehealth indicator.
70.8% of these 24 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 84% from 634 in 2019 to 102 in 2023.
- 2019: 634
- 2020: 195
- 2021: 252
- 2022: 205
- 2023: 102
-
Medicare-allowed amount
Medicare-allowed amount decreased 75% from $67,411 in 2019 to $17,062 in 2023.
- 2019: $67,411
- 2020: $26,523
- 2021: $40,157
- 2022: $33,024
- 2023: $17,062
-
Paid by Medicare
Paid by Medicare decreased 74% from $52,919 in 2019 to $13,594 in 2023.
- 2019: $52,919
- 2020: $20,281
- 2021: $32,191
- 2022: $26,323
- 2023: $13,594
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 65% from 2,462 in 2020 to 855 in 2024.
- 2020: 2,462
- 2021: 1,015
- 2022: 1,551
- 2023: 1,350
- 2024: 855
-
30-day fills
30-day fills decreased 80% from 4,687 in 2020 to 946 in 2024.
- 2020: 4,687
- 2021: 1,226
- 2022: 1,726
- 2023: 1,500
- 2024: 946
-
Part D drug cost
Part D drug cost decreased 66% from $80,023 in 2020 to $27,319 in 2024.
- 2020: $80,023
- 2021: $33,744
- 2022: $51,664
- 2023: $37,365
- 2024: $27,319
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2019 only.
Sources: CMS Medicare Physician & Other Practitioners (2023), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2019), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2019 (payments made January 1 – December 31, 2019): fewer than 11 records totaling $134.70.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $20.88 |
| Boehringer Ingelheim Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
STIOLTO RESPIMAT | General | $16.20 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
LYRICA | General | $12.77 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
LYRICA | General | $12.71 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
LYRICA | General | $12.71 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $12.59 |
| Bausch Health Americas, Inc. |
Food and Beverage
In-kind items and services
|
XIFAXAN | General | $12.47 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
CHANTIX | General | $11.64 |
| Merck Sharp & Dohme Corporation |
Food and Beverage
In-kind items and services
|
JANUVIA | General | $11.47 |
| Merck Sharp & Dohme Corporation |
Food and Beverage
In-kind items and services
|
JANUVIA | General | $11.26 |
Source: CMS Open Payments, program year 2019, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2022 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2023; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
85 | 76 | $300.00 | $176.50 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
17 | 16 | $125.00 | $121.14 |
Source: CMS Part B by Provider and Service, 2023; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 94 | 3,083 | $813.54 | 20 |
| Tamsulosin Hcl | Tamsulosin Hcl | 74 | 2,187 | $612.62 | 16 |
| Lisinopril | Lisinopril | 38 | 1,350 | $206.59 | — |
| Eliquis | Apixaban | 36 | 777 | $15,687.76 | — |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 35 | 740 | $286.62 | — |
| Pantoprazole Sodium | Pantoprazole Sodium | 32 | 919 | $370.04 | — |
| Citalopram Hbr | Citalopram Hydrobromide | 29 | 832 | $88.57 | — |
| Morphine Sulfate | Morphine Sulfate | 28 | 207 | $397.23 | 25 |
| Lorazepam | Lorazepam | 27 | 201 | $166.46 | 25 |
| Haloperidol Lactate | Haloperidol Lactate | 26 | 436 | $434.13 | 24 |
| Clopidogrel | Clopidogrel Bisulfate | 25 | 577 | $204.88 | — |
| Potassium Chloride | Potassium Chloride | 24 | 518 | $285.22 | — |
| Pregabalin | Pregabalin | 23 | 405 | $482.58 | — |
| Amlodipine Besylate | Amlodipine Besylate | 22 | 561 | $57.66 | — |
| Quetiapine Fumarate | Quetiapine Fumarate | 22 | 410 | $132.02 | — |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 20 | 221 | $156.24 | 16 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 20 | 142 | $67.10 | 17 |
| Aripiprazole | Aripiprazole | 20 | 281 | $161.48 | — |
| Mirtazapine | Mirtazapine | 19 | 343 | $199.68 | — |
| Bethanechol Chloride | Bethanechol Chloride | 19 | 326 | $389.50 | — |
| Donepezil Hcl | Donepezil Hcl | 18 | 375 | $36.28 | — |
| Furosemide | Furosemide | 18 | 849 | $73.65 | — |
| Latanoprost | Latanoprost | 17 | 533 | $227.89 | — |
| Metoprolol Tartrate | Metoprolol Tartrate | 16 | 367 | $74.09 | — |
| Omeprazole | Omeprazole | 15 | 417 | $69.18 | — |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine
Doctor of Medicine (M.D.)
Internal Medicine
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1225 S LATSON RD, STE 200, HOWELL, MI 488437660 (Tel: 8104946800)
NPI status registered as active in NPPES database
Registered at 2305 GENOA BUSINESS PARK DR, SUITE 120, BRIGHTON, MI 481147004 (Tel: 8104946800)
Registered at 2305 GENOA BUSINESS PARK DR, SUITE 120, BRIGHTON, MI 481147004 (Tel: 8104946800)
Recorded as MOHAMMAD NADEEMULLAH, M. D.
Internal Medicine (license number reported to NPPES: MI 057016)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine Providers in Brighton
- Dr. Michael Sills, MD
- Dr. Caitlin Peirce, MD
- Dr. Syed Nasser, MD
- Dr. Annissa Hammoud, MD
- Dr. Mark Ealovega, MD
- Dr. Jeffrey Borgeson, MD
Mailing Address
1225 S Latson Rd, Ste 200
Howell, MI 488437660
Phone: 8104946800